Effectiveness and safety of mycophenolate mofetil in idiopathic pulmonary fibrosis.

Currently available antifibrotic treatments may slow down disease progression in idiopathic pulmonary fibrosis (IPF), but are associated with potentially significant side effects and are costly. Mycophenolate mofetil (MMF) is well known for its potent immunosuppressive properties and possesses impor...

Full description

Bibliographic Details
Main Authors: Anoop M Nambiar, Antonio R Anzueto, Jay I Peters
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5404863?pdf=render

Similar Items